Rotigotine hydrochloride is a non-ergot dopamine agonist mainly used to treat the symptoms of Parkinson’s disease and moderate-to-severe restless legs syndrome (RLS). It is administered via a once-daily transdermal patch to provide a continuous, steady supply of the medication through the skin. Its therapeutic use is listed as central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include N-0923 hydrochloride and (6S)-rotigotine hydrochloride. Its PubChem CID is 180335.
Rotigotine hydrochloride
| CAS No | 125572-93-2 |
|---|---|
| Molecular Formula | C19H26ClNOS |
| Molecular Weight | 351.9 g/mol |
| Synonyms | (6S)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Rotigotine hydrochloride is a non-ergot dopamine agonist mainly used to treat the symptoms of Parkinson's disease and moderate-to-severe restless legs syndrome (RLS).
The listed CAS number is 125572-93-2.
The listed molecular formula is C19H26ClNOS.
The listed molecular weight is 351.9 g/mol.
(6S)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol;hydrochloride.
The source lists N-0923 hydrochloride and (6S)-rotigotine hydrochloride.